Quantitative analysis of mucociliary clearance in airway ciliopathies
Project Number1R01HL153622-01A1
Former Number1R01HL153622-01
Contact PI/Project LeaderRYAN, AMY LEANNE Other PIs
Awardee OrganizationUNIVERSITY OF SOUTHERN CALIFORNIA
Description
Abstract Text
PROJECT SUMMARY
Mucociliary clearance (MCC) is a critical mechanical defense mechanism of the human respiratory system.
Poor MCC is a fundamental feature of many inherited and acquired respiratory diseases including primary
ciliary dyskinesia (PCD), asthma, chronic bronchitis, and cystic fibrosis (CF). Due to the complex organization
of the lung, it is largely unknown how defects of the ciliary machinery change functional MCC and how regional
variability of airway epithelial structure, including cell type proportions and ciliary beat parameters, affect local
MCC pathophysiology. These knowledge gaps dramatically impair our ability to predict the degree of pulmonary
dysfunction imparted by specific ciliary defects, and to understand the airway region-specific onset observed in
many lung diseases. While impaired MCC is a pre-determined functional consequence of PCD and other
chronic lung diseases, to date, there is no established in vitro model that is able to accurately predict the
relationship between genotype, cilia motility, MCC, and respiratory phenotype and, therefore, many
genotype-phenotype relationships remain unexplained. Our transdisciplinary research program is designed
to address an unmet need to understand how a) region-specific airway organization and b) ciliopathy-
causing genotypes, impact MCC. To achieve this we will complete specific aims designed to: 1) use ex vivo
lung tissues, that retain their in vivo epithelial organization, as models of ciliated airway epithelia to
comprehensively evaluate biomechanical structure-function relationships in large and small airways (Aim 1); 2)
use established in vitro models of the human tracheo-bronchial (large) airways to determine a minimal set of
structural and functional parameters that are conserved between in vitro and ex vivo ciliated tissues (Aim 2); 3)
apply state-of-the-art physics-based computational approaches to develop an in silico model that will be able
to predict structure-function relationships of ciliated tissues (Aim 3) and 4) use the minimal set of parameters
that define functional MCC in both in vitro and ex vivo models as input into the in silico model to predict regional-
specific changes in MCC due to ciliary defects in both large and small airways (All Aims). Our specific objectives
build to our long-term goal of combining in vitro and in silico models as a preclinical, precision medicine
tool for evaluating small molecule or gene-editing therapeutics toward more targeted and efficient
treatment regimens of pulmonary diseases characterized by poor mucociliary clearance.
Public Health Relevance Statement
PROJECT NARRATIVE:
The airways are lined by dense fields of motile cilia that generate a directional fluid flow that is critical for clearing
mucus, pathogens, and debris from the airways. Disruptions in the ciliary apparatus, whether due to a genetic
disorder or infective and acquired causes, are directly linked to infection and disease progression. The goal of
this study is to better understand how the spatial organization of the airway epithelium regulates airway clearance
in diseases characterized by genetic changes in motile cilia.
1
No Sub Projects information available for 1R01HL153622-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HL153622-01A1
Patents
No Patents information available for 1R01HL153622-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HL153622-01A1
Clinical Studies
No Clinical Studies information available for 1R01HL153622-01A1
News and More
Related News Releases
No news release information available for 1R01HL153622-01A1
History
No Historical information available for 1R01HL153622-01A1
Similar Projects
No Similar Projects information available for 1R01HL153622-01A1